162
Participants
Start Date
April 30, 2007
Primary Completion Date
February 29, 2012
Study Completion Date
February 29, 2012
CP-690,550
Subjects had to have received CP-690,550 or other blinded study drug in index study. No intervention in this long-term follow-up trial.
Pfizer Investigational Site, Sofia
Pfizer Investigational Site, Athens
Pfizer Investigational Site, Mexico City
Pfizer Investigational Site, Genova
Pfizer Investigational Site, Guadalajara
Pfizer Investigational Site, Wyomissing
Pfizer Investigational Site, Vinnitsa
Pfizer Investigational Site, Hickory
Pfizer Investigational Site, Hickory
Pfizer Investigational Site, Orlando
Pfizer Investigational Site, Tampa
Pfizer Investigational Site, Tampa
Pfizer Investigational Site, Sarasota
Pfizer Investigational Site, Venice
Pfizer Investigational Site, Ocala
Pfizer Investigational Site, Florence
Pfizer Investigational Site, Rockford
Pfizer Investigational Site, Lincoln
Pfizer Investigational Site, Mesquite
Pfizer Investigational Site, Bratislava
Pfizer Investigational Site, Gilbert
Pfizer Investigational Site, Tucson
Pfizer Investigational Site, Upland
Pfizer Investigational Site, San Diego
Pfizer Investigational Site, Palo Alto
Pfizer Investigational Site, Stanford
Pfizer Investigational Site, Tacoma
Pfizer Investigational Site, Providencia
Pfizer Investigational Site, Santiago
Pfizer Investigational Site, Santiago
Pfizer Investigational Site, Albany
Pfizer Investigational Site, Tacoma
Pfizer Investigational Site, Buenos Aires
Pfizer Investigational Site, Buenos Aires
Pfizer Investigational Site, Goiânia
Pfizer Investigational Site, Rio de Janeiro
Pfizer Investigational Site, São Paulo
Pfizer Investigational Site, São Paulo
Pfizer Investigational Site, Victoria
Pfizer Investigational Site, Brno
Pfizer Investigational Site, České Budějovice
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Praha 11 - Chodov
Pfizer Investigational Site, Santo Domingo
Pfizer Investigational Site, Hyvinkää
Pfizer Investigational Site, Thessaloniki
Pfizer Investigational Site, Budapest
Pfizer Investigational Site, Szolnok
Pfizer Investigational Site, Veszprém
Pfizer Investigational Site, Ahmedabad
Pfizer Investigational Site, Mangalore
Pfizer Investigational Site, Pune
Pfizer Investigational Site, Kitakyushu
Pfizer Investigational Site, Higashihiroshima
Pfizer Investigational Site, Sagamihara
Pfizer Investigational Site, Shinjyuku-ku
Pfizer Investigational Site, México
Pfizer Investigational Site, Bialystok
Pfizer Investigational Site, Poznan
Pfizer Investigational Site, Sopot
Pfizer Investigational Site, Warsaw
Pfizer Investigational Site, Wroclaw
Pfizer Investigational Site, San Juan
Pfizer Investigational Site, Piešťany
Pfizer Investigational Site, Žilina
Pfizer Investigational Site, Daejeon
Pfizer Investigational Site, Gwangju
Pfizer Investigational Site, Incheon
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Lead Sponsor
Pfizer
INDUSTRY